This Opposition was filed at the USPTO Trademark Trial and Appeal Board (TTAB) on May 16, 2022 and assigned serial number 91276241 by the TTAB.

Defendant:
Chugai Seiyaku Kabushiki Kaisha (ChugaiPharmaceutical Co., Ltd.) represented by BASSAM N. IBRAHIM of BUCHANAN INGERSOLL & ROONEY PC.
Trademark Information: UPIQLA – US Trademark Serial Number 90570533
View Trademark Status at USPTO
View Trademark Documents at USPTO

Plaintiff:
Theravance Biopharma Ireland Limited represented by BETH H. ALTER of SEWARD & KISSEL LLP.
Trademark Information: UPBALA – US Trademark Serial Number 79305420
View Trademark Status at USPTO
View Trademark Documents at USPTO

Prosecution History:
May 16, 2022 – FILED AND FEE
May 17, 2022 – NOTICE AND TRIAL DATES SENT; ANSWER DUE:
May 17, 2022 – INSTITUTED
June 17, 2022 – ANSWER
July 13, 2022 – P MOT FOR EXT W/ CONSENT
July 13, 2022 – EXTENSION OF TIME GRANTED
September 19, 2022 – P MOT FOR EXT W/ CONSENT
September 20, 2022 – EXTENSION OF TIME GRANTED
November 18, 2022 – P MOT FOR EXT W/ CONSENT
November 18, 2022 – EXTENSION OF TIME GRANTED
January 19, 2023 – D MOT FOR EXT W/ CONSENT
January 19, 2023 – EXTENSION OF TIME GRANTED
March 22, 2023 – P MOT FOR EXT W/ CONSENT
March 22, 2023 – EXTENSION OF TIME GRANTED
April 14, 2023 – W/DRAW OF OPPOSITION
April 17, 2023 – BD DECISION: OPP DISMISSED W/O PREJ
April 17, 2023 – TERMINATED
View this TTAB Proceeding at USPTO

About Select IP
Select IP Law Corporation monitors TTAB proceedings that have been instituted. We are experts in trademark law. If you are interested in connecting with an IP law attorney or patent law attorney, please contact us via the contact form.